Tag Archives: Kevin Steinke

Barrington Remains a Buy on SP Plus (SP)

Barrington analyst Kevin Steinke reiterated a Buy rating on SP Plus (SP – Research Report) today and set a price target of $29.00. The company’s shares closed last Friday at $20.60. According to TipRanks.com, Steinke is a 4-star analyst with

Barrington Maintains a Buy Rating on Sharps Compliance (SMED)

In a report released today, Kevin Steinke from Barrington maintained a Buy rating on Sharps Compliance (SMED – Research Report), with a price target of $9.00. The company’s shares closed last Friday at $7.66. According to TipRanks.com, Steinke is a

Barrington Keeps Their Buy Rating on Cross Country Healthcare (CCRN)

Barrington analyst Kevin Steinke reiterated a Buy rating on Cross Country Healthcare (CCRN – Research Report) today and set a price target of $9.00. The company’s shares closed last Wednesday at $6.67. According to TipRanks.com, Steinke is a 4-star analyst

Analysts Offer Insights on Services Companies: SP Plus (NASDAQ: SP) and Quotient Technology (NYSE: QUOT)

There’s a lot to be optimistic about in the Services sector as 2 analysts just weighed in on SP Plus (SP – Research Report) and Quotient Technology (QUOT – Research Report) with bullish sentiments. SP Plus (SP) In a report

Analysts Offer Insights on Services Companies: Lawson Products (NASDAQ: LAWS) and Booking Holdings (NASDAQ: BKNG)

Companies in the Services sector have received a lot of coverage today as analysts weigh in on Lawson Products (LAWS – Research Report) and Booking Holdings (BKNG – Research Report). Lawson Products (LAWS) In a report released today, Kevin Steinke

What Made Barrington Downgrade Stericycle’s Stock?

In a report released today, Kevin Steinke from Barrington downgraded Stericycle (SRCL – Research Report) to Hold. The company’s shares closed last Monday at $61.22. According to TipRanks.com, Steinke is a 1-star analyst with an average return of -1.1% and